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CASE PRESENTATION
A 26-year-old female presented to the emergency department (ED) with progressively worsening forehead erythema and discomfort after receiving an injection of hyaluronic acid filler into the glabella at a medical spa the previous day. On arrival to the ED she was afebrile with normal vital signs. Physical examination revealed blanchable erythema extending from the mid-forehead to the nasal Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts bridge in a linear distribution with early retiform appearance on the nasal sidewalls (Image). The patient denied visual symptoms, and ophthalmic examination was normal. She was diagnosed with vascular occlusion as a result of hyaluronic acid filler injection.
She was treated with an intradermal injection of 490U hyaluronidase (2.45mL of 200U/mL) administered in multiple small injections around the linear erythema. After the injection, a single dose of 2% nitroglycerin paste was applied to the skin for five minutes. She was discharged home on a two-week course of aspirin 325mg daily. The patient had outpatient follow-up one day and four days after her initial presentation. She had complete resolution of symptoms.
DISCUSSION
Vascular occlusion is a rare but potentially detrimental complication of hyaluronic acid filler injections. It results from accidental injection of filler into an artery, or compression of the artery from surrounding filler.
1 Vascular occlusion can rapidly progress to tissue necrosis if not identified and treated quickly. Retinal branch artery occlusion is also a potential complication of filler injections, caused by retrograde arteriolar flow of the filler into the branches of the ophthalmic artery. 2 It is imperative to ask about visual symptoms and perform a thorough ophthalmic examination in these patients. The treatment of hyaluronic acid-induced vascular occlusion involves intradermal injection of hyaluronidase, a protein enzyme that degrades hyaluronic acid. Patients may also benefit from topical nitroglycerin paste to facilitate vasodilation, although this is controversial. Experts also recommend a short-term aspirin regimen to prevent further clotting and vascular compromise. 
CPC-EM Capsule

